Literature DB >> 35001366

Self-management interventions for people with chronic obstructive pulmonary disease.

Jade Schrijver1,2, Anke Lenferink1,3, Marjolein Brusse-Keizer3,4, Marlies Zwerink5, Paul Dlpm van der Valk1, Job van der Palen2,4, Tanja W Effing6,7.   

Abstract

BACKGROUND: Self-management interventions help people with chronic obstructive pulmonary disease (COPD) to acquire and practise the skills they need to carry out disease-specific medical regimens, guide changes in health behaviour and provide emotional support to enable them to control their disease. Since the 2014 update of this review, several studies have been published.
OBJECTIVES: Primary objectives To evaluate the effectiveness of COPD self-management interventions compared to usual care in terms of health-related quality of life (HRQoL) and respiratory-related hospital admissions. To evaluate the safety of COPD self-management interventions compared to usual care in terms of respiratory-related mortality and all-cause mortality. Secondary objectives To evaluate the effectiveness of COPD self-management interventions compared to usual care in terms of other health outcomes and healthcare utilisation. To evaluate effective characteristics of COPD self-management interventions. SEARCH
METHODS: We searched the Cochrane Airways Trials Register, CENTRAL, MEDLINE, EMBASE, trials registries and the reference lists of included studies up until January 2020. SELECTION CRITERIA: Randomised controlled trials (RCTs) and cluster-randomised trials (CRTs) published since 1995. To be eligible for inclusion, self-management interventions had to include at least two intervention components and include an iterative process between participant and healthcare provider(s) in which goals were formulated and feedback was given on self-management actions by the participant. DATA COLLECTION AND ANALYSIS: Two review authors independently selected studies for inclusion, assessed trial quality and extracted data. We resolved disagreements by reaching consensus or by involving a third review author. We contacted study authors to obtain additional information and missing outcome data where possible. Primary outcomes were health-related quality of life (HRQoL), number of respiratory-related hospital admissions, respiratory-related mortality, and all-cause mortality. When appropriate, we pooled study results using random-effects modelling meta-analyses. MAIN
RESULTS: We included 27 studies involving 6008 participants with COPD. The follow-up time ranged from two-and-a-half to 24 months and the content of the interventions was diverse. Participants' mean age ranged from 57 to 74 years, and the proportion of male participants ranged from 33% to 98%. The post-bronchodilator forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) ratio of participants ranged from 33.6% to 57.0%. The FEV1/FVC ratio is a measure used to diagnose COPD and to determine the severity of the disease. Studies were conducted on four different continents (Europe (n = 15), North America (n = 8), Asia (n = 1), and Oceania (n = 4); with one study conducted in both Europe and Oceania). Self-management interventions likely improve HRQoL, as measured by the St. George's Respiratory Questionnaire (SGRQ) total score (lower score represents better HRQoL) with a mean difference (MD) from usual care of -2.86 points (95% confidence interval (CI) -4.87 to -0.85; 14 studies, 2778 participants; low-quality evidence). The pooled MD of -2.86 did not reach the SGRQ minimal clinically important difference (MCID) of four points. Self-management intervention participants were also at a slightly lower risk for at least one respiratory-related hospital admission (odds ratio (OR) 0.75, 95% CI 0.57 to 0.98; 15 studies, 3263 participants; very low-quality evidence). The number needed to treat to prevent one respiratory-related hospital admission over a mean of 9.75 months' follow-up was 15 (95% CI 8 to 399) for participants with high baseline risk and 26 (95% CI 15 to 677) for participants with low baseline risk. No differences were observed in respiratory-related mortality (risk difference (RD) 0.01, 95% CI -0.02 to 0.04; 8 studies, 1572 participants ; low-quality evidence) and all-cause mortality (RD -0.01, 95% CI -0.03 to 0.01; 24 studies, 5719 participants; low-quality evidence). We graded the evidence to be of 'moderate' to 'very low' quality according to GRADE. All studies had a substantial risk of bias, because of lack of blinding of participants and personnel to the interventions, which is inherently impossible in a self-management intervention. In addition, risk of bias was noticeably increased because of insufficient information regarding a) non-protocol interventions, and b) analyses to estimate the effect of adhering to interventions. Consequently, the highest GRADE evidence score that could be obtained by studies was 'moderate'. AUTHORS'
CONCLUSIONS: Self-management interventions for people with COPD are associated with improvements in HRQoL, as measured with the SGRQ, and a lower probability of respiratory-related hospital admissions. No excess respiratory-related and all-cause mortality risks were observed, which strengthens the view that COPD self-management interventions are unlikely to cause harm. By using stricter inclusion criteria, we decreased heterogeneity in studies, but also reduced the number of included studies and therefore our capacity to conduct subgroup analyses. Data were therefore still insufficient to reach clear conclusions about effective (intervention) characteristics of COPD self-management interventions. As tailoring of COPD self-management interventions to individuals is desirable, heterogeneity is and will likely remain present in self-management interventions. For future studies, we would urge using only COPD self-management interventions that include iterative interactions between participants and healthcare professionals who are competent using behavioural change techniques (BCTs) to elicit participants' motivation, confidence and competence to positively adapt their health behaviour(s) and develop skills to better manage their disease. In addition, to inform further subgroup and meta-regression analyses and to provide stronger conclusions regarding effective COPD self-management interventions, there is a need for more homogeneity in outcome measures. More attention should be paid to behavioural outcome measures and to providing more detailed, uniform and transparently reported data on self-management intervention components and BCTs. Assessment of outcomes over the long term is also recommended to capture changes in people's behaviour. Finally, information regarding non-protocol interventions as well as analyses to estimate the effect of adhering to interventions should be included to increase the quality of evidence.
Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2022        PMID: 35001366      PMCID: PMC8743569          DOI: 10.1002/14651858.CD002990.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  382 in total

1.  Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD).

Authors:  Laura M Cecere; Christopher G Slatore; Jane E Uman; Laura E Evans; Edmunds M Udris; Chris L Bryson; David H Au
Journal:  COPD       Date:  2012-04-12       Impact factor: 2.409

2.  Evaluation of a Nurse-Led Educational Telephone Intervention to Support Self-Management of Patients With Chronic Obstructive Pulmonary Disease: A Randomized Feasibility Study.

Authors:  Julia Billington; Samantha Coster; Trevor Murrells; Ian Norman
Journal:  COPD       Date:  2015-08       Impact factor: 2.409

3.  The effect of an outpatient care on-demand-system on health status and costs in patients with COPD. A randomized trial.

Authors:  Farida F Berkhof; Anne M Hesselink; Dominique L C Vaessen; Steven M Uil; Huib A M Kerstjens; Jan W K van den Berg
Journal:  Respir Med       Date:  2014-06-03       Impact factor: 3.415

4.  Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial.

Authors:  Kathryn L Rice; Naresh Dewan; Hanna E Bloomfield; Joseph Grill; Tamara M Schult; David B Nelson; Sarita Kumari; Mel Thomas; Lois J Geist; Caroline Beaner; Michael Caldwell; Dennis E Niewoehner
Journal:  Am J Respir Crit Care Med       Date:  2010-01-14       Impact factor: 21.405

5.  Disease-specific education in the primary care setting increases the knowledge of people with chronic obstructive pulmonary disease: a randomized controlled trial.

Authors:  Kylie Hill; Suzanna Mangovski-Alzamora; Maria Blouin; Gordon Guyatt; Diane Heels-Ansdell; Pauline Bragaglia; Itamar Tamari; Karen Jones; Roger Goldstein
Journal:  Patient Educ Couns       Date:  2009-10-22

6.  Effectiveness of community-based integrated care in frail COPD patients: a randomised controlled trial.

Authors:  Carme Hernández; Albert Alonso; Judith Garcia-Aymerich; Ignasi Serra; Dolors Marti; Robert Rodriguez-Roisin; Georgia Narsavage; Maria Carmen Gomez; Josep Roca
Journal:  NPJ Prim Care Respir Med       Date:  2015-04-09       Impact factor: 2.871

7.  Inhaler technique education in elderly patients with asthma or COPD: impact on disease exacerbations-a protocol for a single-blinded randomised controlled trial.

Authors:  Tiago Maricoto; Jaime Correia-de-Sousa; Luís Taborda-Barata
Journal:  BMJ Open       Date:  2019-01-28       Impact factor: 2.692

8.  Evaluating the integration of chronic disease prevention and management services into primary health care.

Authors:  Martin Fortin; Maud-Christine Chouinard; Tarek Bouhali; Marie-France Dubois; Cynthia Gagnon; Martin Bélanger
Journal:  BMC Health Serv Res       Date:  2013-04-08       Impact factor: 2.655

9.  A telehealth program for self-management of COPD exacerbations and promotion of an active lifestyle: a pilot randomized controlled trial.

Authors:  Monique Tabak; Marjolein Brusse-Keizer; Paul van der Valk; Hermie Hermens; Miriam Vollenbroek-Hutten
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-09-09

10.  Findings of the Chronic Obstructive Pulmonary Disease-Sitting and Exacerbations Trial (COPD-SEAT) in Reducing Sedentary Time Using Wearable and Mobile Technologies With Educational Support: Randomized Controlled Feasibility Trial.

Authors:  Lauren B Sherar; Sally J Singh; Mark W Orme; Amie E Weedon; Paula M Saukko; Dale W Esliger; Mike D Morgan; Michael C Steiner; John W Downey
Journal:  JMIR Mhealth Uhealth       Date:  2018-04-11       Impact factor: 4.773

View more
  5 in total

1.  The Long-Term Maintenance Effect of Remote Pulmonary Rehabilitation via Social Media in COPD: A Randomized Controlled Trial.

Authors:  Yi Li; Hongyu Qian; Kewei Yu; Ying Huang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-05-11

2.  Systematic review of effectiveness and quality assessment of patient education materials and decision aids for breathlessness.

Authors:  Anthony Paulo Sunjaya; Lexia Bao; Allison Martin; Gian Luca DiTanna; Christine R Jenkins
Journal:  BMC Pulm Med       Date:  2022-06-20       Impact factor: 3.320

3.  Supporting Behavior Change After AECOPD - Development of a Hospital-Initiated Intervention Using the Behavior Change Wheel.

Authors:  Paul Chadwick; Christian Clarenbach; Gabriela Schmid-Mohler; Christine Hübsch; Claudia Steurer-Stey; Nico Greco; Macé M Schuurmans; Sonja Beckmann
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-07-26

4.  Multidisciplinary care in chronic airway diseases: the Newcastle model.

Authors:  Vanessa M McDonald; John Harrington; Vanessa L Clark; Peter G Gibson
Journal:  ERJ Open Res       Date:  2022-08-15

5.  Peer Support and Chronic Obstructive Pulmonary Disease Self-Management: A Promising Approach?

Authors:  Vincent S Fan; David B Coultas
Journal:  Ann Am Thorac Soc       Date:  2022-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.